Abstract:Objective: To investigate the effect of manganese chloride (MnCl(2)) or 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP) on the neurobehavioral and histopathology in C57BL/6 mice and provide evidence for the diagnosis, treatment and prevention of manganism. Methods: Adult male C57BL/6 mice were treated with MnCl(2) and MPTP respectively by intraperitoneal injection at the doses of 5, 10, 20mg Mn/kg and 30mg MPTP/kg. Controls were injected equivalent normal saline. All animals were administrated 5 times a week for 4 consecutive weeks and sacrificed after behavior tests on the fifth week. Balance ability, anxiety and depression level and cognitive function were tested respectively by vertical pole test, open field locomotion test and Morris swim task. The neuron pathological changes of striatum and substantia nigra were examined through HE-staining pathological section by using optical microscope. Results: Compared with the control group, the high dose of MnCl(2) reduced body weight obviously (P<0.01) . The results of vertical pole test showed that MnCl(2) and MPTP lengthened the pole-climbing time and turnaround time. Open field locomotion test showed that movement distance, stand-up time and central field time were decreased after the exposure of MnCl(2) or MPTP. In the Morris swim task, the escape latency time increased and the target quadrant activity time decreased significantly after the injection of MPTP as well as high-dose MnCl(2), comparing with controls (P<0.05) . Moreover, the escape latency time of high dose MnCl(2) prolonged prominently comparing with MPTP grou (P<0.05) . The results of histopathology showed that acidophilic changes elevated in MnCl(2) and MPTP group, comparing with controls. Furthermore, in striatum the oxyphil cells number increased in MnCl(2) high-dose group comparing with MPTP group (P<0.01) . On the contrary, there were more oxyphil cells in MPTP group comparing with MnCl(2) groups in substantia nigra (P<0.01) . Conclusion: Both manganese and MPTP can induce the impairment of dopaminergic neural system, but the symptons and injured location of manganism are inconsistent with PD models induced by MPTP.

Chronic Manganese Administration with Longer Intervals Between Injections Produced Neurotoxicity and Hepatotoxicity in Rats.

Subchronic, Low-Level Intraperitoneal Injections of Manganese (IV) Oxide and Manganese (II) Chloride Affect Rat Brain Neurochemistry

Manganese Induces Dopaminergic Neurodegeneration Via Microglial Activation in a Rat Model of Manganism.

Manganese overexposure induces Parkinson-like symptoms, altered lipid signature and oxidative stress in C57BL/6 J mouse

Manganese Induces Neuroinflammation Via NF-κB/ROS NLRP3 Pathway in Rat Brain Striatum and HAPI Cells

Methylcyclopentadienyl Manganese Tricarbonyl Alter Behavior and Cause Ultrastructural Changes in the Substantia Nigra of Rats: Comparison with Inorganic Manganese Chloride

Intrastriatal Manganese Chloride Exposure Causes Acute Locomotor Impairment As Well As Partial Activation of Substantia Nigra GABAergic Neurons

[The Comparison of Neurobehavioral Changes and Impaired Locations Between the Mouse Model of Manganism and Parkinson's Disease].

Subacute toxicity of exogenous manganese on rat hippocampal neurons Examination by MRI and optical microscopy

Manganese Exposure Causes Movement Deficit and Changes in the Protein Profile of the External Globus Pallidus in Sprague Dawley Rats.

Repeated Manganese Administration Produced Abnormal Expression of Circadian Clock Genes in the Hypothalamus and Liver of Rats.

Manganese Causes Neurotoxic Iron Accumulation Via Translational Repression of Amyloid Precursor Protein and H‐Ferritin

Manganese Intoxication Recovery and the Expression Changes of Park2/Parkin in Rats

Manganese Injection into the Rat Striatum Produces Excitotoxic Lesions by Impairing Energy Metabolism

Effect of manganese chloride exposure on liver and brain mitochondria function in rats.

Manganese exposure leads to depressive-like behavior through disruption of the Gln-Glu-GABA metabolic cycle

Manganese exposure leads to depressive-like behavior through disruption of the GlnGluGABA metabolic cycle

Waterborne manganese exposure alters plasma, brain, and liver metabolites accompanied by changes in stereotypic behaviors.

The Gut Microbiota Confers Protection in the CNS Against Neurodegeneration Induced by Manganism

Manganese induces oxidative damage in the hippocampus by regulating the expression of oxidative stress‐related genes via modulation of H3K18 acetylation

ER Stress and ER Stress-Mediated Apoptosis Are Involved in Manganese-Induced Neurotoxicity in the Rat Striatum in Vivo.